Tomoya Fukui

1.6k total citations
63 papers, 1.1k citations indexed

About

Tomoya Fukui is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tomoya Fukui has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Tomoya Fukui's work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (22 papers) and Neuroendocrine Tumor Research Advances (12 papers). Tomoya Fukui is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (22 papers) and Neuroendocrine Tumor Research Advances (12 papers). Tomoya Fukui collaborates with scholars based in Japan, United States and United Kingdom. Tomoya Fukui's co-authors include Yuichiro Ohe, Koh Furuta, Koji Tsuta, Toshimi Takano, Satoshi Igawa, Hiroshi Nokihara, Noboru Yamamoto, Hideo Kunitoh, Ikuo Sekine and Tomohide Tamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tomoya Fukui

55 papers receiving 1.1k citations

Peers

Countries citing papers authored by Tomoya Fukui

Since Specialization

Citations

This map shows the geographic impact of Tomoya Fukui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Fukui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Fukui more than expected).

Fields of papers citing papers by Tomoya Fukui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Fukui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Fukui. The network helps show where Tomoya Fukui may publish in the future.

Co-authorship network of co-authors of Tomoya Fukui

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Fukui. A scholar is included among the top collaborators of Tomoya Fukui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Fukui. Tomoya Fukui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01 2024 ·Targeted Oncology ·Makoto Hibino, Yoshinori Imamura, Rai Shimoyama, Tomoya Fukui, Ryuta Fukai, Akihiko Iwase, (unknown), Yusuke Chihara, Takafumi Okabe, (unknown), (unknown), Masataka Taguri, Hironobu Minami	3
2	Successful coil embolization of a ruptured aneurysm of the arc of Riolan artery 2022 ·SHILAP Revista de lepidopterología ·(unknown), Tetsuo Sonomura, (unknown), Akira Ikoma, (unknown), Tomoya Fukui, (unknown), (unknown), (unknown), (unknown), (unknown), Ryota Tanaka, Takao Koyama, Hiroki Minamiguchi	0
3	<p>Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer</p> 2020 ·Cancer Management and Research ·Satoshi Igawa, (unknown), Masashi Kasajima, Hideaki Manabe, Tomoya Fukui, Hisashi Mitsufuji, Masanori Yokoba, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki	2
4	Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors 2020 ·Investigational New Drugs ·(unknown), Satoshi Igawa, (unknown), (unknown), (unknown), (unknown), (unknown), Tomoya Fukui, Jiichiro Sasaki, Hisashi Mitsufuji, Masanori Yokoba, Masaru Kubota, Masato Katagiri, Katsuhiko Naoki	14
5	EP1.01-68 Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study 2019 ·Journal of Thoracic Oncology ·Satoshi Igawa, Takaaki Ono, Tetsuya Ozawa, Hideyuki Sone, (unknown), Shinji Harada, (unknown), Masashi Kasajima, Yasuhiro Hiyoshi, Tomoya Fukui, Masaru Kubota, Jiichiro Sasaki, Hisashi Mitsufuji, Katsuhiko Naoki	1
6	<p>Impact of <em>EGFR </em>genotype on the efficacy of osimertinib in <em>EGFR </em>tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study</p> 2019 ·Cancer Management and Research ·Satoshi Igawa, (unknown), Masashi Kasajima, (unknown), Yasuhiro Hiyoshi, (unknown), (unknown), Tomoya Fukui, Masaru Kubota, Jiichiro Sasaki, Hisashi Mitsufuji, Masanori Yokoba, Masato Katagiri, Katsuhiko Naoki	17
7	Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring <b><i>EGFR</i></b> Mutations 2018 ·Oncology ·(unknown), Satoshi Igawa, Masashi Kasajima, (unknown), (unknown), (unknown), (unknown), (unknown), Tomoya Fukui, Hisashi Mitsufuji, Masanori Yokoba, Masato Katagiri, Masaru Kubota, Jiichiro Sasaki, Katsuhiko Naoki	9
8	Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer 2018 ·Cancer Management and Research ·Masayuki Shirasawa, Tomoya Fukui, (unknown), Yasuhiro Hiyoshi, (unknown), Masashi Kasajima, Yoshiro Nakahara, Sakiko Otani, Satoshi Igawa, Masanori Yokoba, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki	18
9	Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease 2018 ·Cancer Management and Research ·Satoshi Igawa, (unknown), Akira Takakura, (unknown), (unknown), (unknown), (unknown), (unknown), Hideyuki Sone, Yoshiro Nakahara, Tomoya Fukui, Hisashi Mitsufuji, Masanori Yokoba, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki	9
10	Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status 2018 ·Oncology ·Satoshi Igawa, Masayuki Shirasawa, Tomoya Fukui, (unknown), Hideyuki Sone, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki	4
11	A prospective observational study of immune checkpoint inhibitor nivolumab treatment in patients with non-small cell lung cancer 2017 ·Annals of Oncology ·Tomoya Fukui, Yoshiro Nakahara, Sakiko Otani, Masato Katagiri, Hisashi Mitsufuji, Masaru Kubota, Yasuhiro Hiyoshi, (unknown), Masashi Kasajima, Satoshi Igawa, Jiichiro Sasaki	1
12	Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non–small cell lung cancer 2017 ·Investigational New Drugs ·Satoshi Igawa, Sakiko Otani, Yoshiro Nakahara, Shinichiro Ryuge, Yasuhiro Hiyoshi, Tomoya Fukui, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Yuichi Sato, Jiichiro Sasaki, Noriyuki Masuda	3
13	Detectability of druggable gene fusions by amplicon-based next generation sequencing in nationwide lung cancer genomic screening project (LC-SCRUM-Japan) 2016 ·Annals of Oncology ·Shingo Matsumoto, Kiyotaka Yoh, (unknown), Kadoaki Ohashi, Sho Saeki, Naoki Furuya, Yuki Nishioka, Y. Ohe, Takashi Seto, Ryuji Hayashi, Yuki Kataoka, Tomoya Fukui, Tomohiro Sakamoto, Shinnosuke Ikemura, Takashi Kohno, K. Tsuta, Katsuya Tsuchihara, Kōichi Goto	0
14	Circulating tumor cells as a prognostic factor in patients with small cell lung cancer 2014 ·Oncology Letters ·Satoshi Igawa, Keigo Gohda, Tomoya Fukui, Shinichiro Ryuge, Sakiko Otani, (unknown), Jun Sato, Katsuhiro Murakami, S. Maki, Ken Katono, Akira Takakura, Jiichiro Sasaki, Yukitoshi Satoh, Noriyuki Masuda	56
15	Critical review of ‘Public domain application’: a flexible drug approval system in Japan 2013 ·Annals of Oncology ·Yuri Ito, Hiroto Narimatsu, Tomoya Fukui, Akira Fukao, Takashi Yoshioka	8
16	Angiotensin II Type 1A Receptor Signaling Facilitates Tumor Metastasis Formation through P-Selectin–Mediated Interaction of Tumor Cells with Platelets and Endothelial Cells 2012 ·American Journal Of Pathology ·Hideki Amano, Yoshiya Ito, Fumihiro Ogawa, Koji Eshima, Tatsunori Suzuki, Kazuhito Oba, Yoshio Matsui, Shintaro Kato, Tomoya Fukui, Masaki Nakamura, Hidero Kitasato, Akiyoshi Fukamizu, Masataka Majima	30
17	Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer 2012 ·Cancer Chemotherapy and Pharmacology ·(unknown), Michiko Yamamoto, (unknown), Shinichiro Ryuge, Ken Katono, Masanori Yokoba, Tomoya Fukui, Akira Takakura, Sakiko Otani, S. Maki, Satoshi Igawa, (unknown), Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Noriyuki Masuda	4
18	Circulating Endothelial Cells in Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel 2009 ·Journal of Thoracic Oncology ·Makoto Kawaishi, Yutaka Fujiwara, Tomoya Fukui, Terufumi Kato, Kazuhiko Yamada, Yuichiro Ohe, Hideo Kunitoh, Ikuo Sekine, Noboru Yamamoto, Hiroshi Nokihara, (unknown), Yuji Shimoda, Tokuzo Arao, Kazuto Nishio, Tomohide Tamura, Fumiaki Koizumi	34
19	Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung disease 2009 ·Cancer Chemotherapy and Pharmacology ·Tomoya Fukui, Sakiko Otani, Ryuji Hataishi, Shi‐Xu Jiang, (unknown), Satoshi Igawa, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Noriyuki Masuda	28
20	Detection ofEGFRMutations in Archived Cytologic Specimens of Non–Small Cell Lung Cancer Using High-Resolution Melting Analysis 2006 ·American Journal of Clinical Pathology ·(unknown), Koji Tsuta, Toshimi Takano, Tomoya Fukui, (unknown), Hiromi Sakamoto, Teruhiko Yoshida, Akiko Miyagi Maeshima, Tatsuhiro Shibata, Koh Furuta, Yuichiro Ohe, Yoshihiro Matsuno	124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact